As of January 22, 2025, Burning Rock Biotech (BNR) has a market cap of $69.862 million USD. According to our data, Burning Rock Biotech is ranked No.7959 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $69.86 M |
21.39%
|
Dec 31, 2024 | $57.55 M |
-27.42%
|
Dec 29, 2023 | $79.29 M |
-58.67%
|
Dec 30, 2022 | $0.19 B |
-76.39%
|
Dec 31, 2021 | $0.81 B |
-58.74%
|
Dec 31, 2020 | $1.97 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Guardant Health
GH
|
$5.83 B |
0.000 M
|
USA
|
Natera
NTRA
|
$22.70 B |
-0.001 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
Agilent Technologies
A
|
$43.58 B |
0.000 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Qiagen
QGEN
|
$10.50 B |
0.000 M
|
Netherlands
|
NeoGenomics
NEO
|
$1.86 B |
0.000 M
|
USA
|
Personalis
PSNL
|
$0.47 B |
0.000 M
|
USA
|
Adaptive Biotechnologies
ADPT
|
$1.18 B |
0.000 M
|
USA
|
Fulgent Genetics
FLGT
|
$0.52 B |
-0.000 M
|
USA
|
Pacific Biosciences
PACB
|
$0.53 B |
-0.000 M
|
USA
|
10x Genomics
TXG
|
$1.97 B |
0.229 B
|
USA
|
Market Cap | = | BNR Stock Price | * | BNR Shares Outstanding |
= | $6.81 | * | 8.53 M | |
= | $69.86 M |